Plant ID: NPO19078
Plant Latin Name: Lophocolea bidentata
Taxonomy Genus: Lophocolea
Taxonomy Family: Lophocoleaceae
NCBI TaxonomyDB:
215269
Plant-of-the-World-Online:
n.a.
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.665E-11 | 3.626E-07 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.832E-10 | 1.994E-06 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 4.983E-09 | 3.617E-05 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.182E-08 | 6.432E-05 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 9.649E-08 | 3.502E-04 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 2.002E-07 | 4.360E-04 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.842E-07 | 5.158E-04 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.578E-07 | 7.877E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 7.235E-07 | 9.267E-04 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.061E-06 | 1.284E-03 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.066E-06 | 2.267E-03 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 2.186E-06 | 2.267E-03 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.375E-06 | 3.340E-03 | CYP2C19, CYP2C9 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.081E-04 | 7.353E-02 | CYP2C19, CYP2C9, CYP3A4 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 2.777E-03 | 9.026E-01 | CYP2C19, CYP2C9, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.741E-09 | 3.015E-08 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.930E-08 | 2.162E-07 | CYP2C9, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 6.643E-08 | 2.436E-07 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.831E-05 | 6.850E-05 | CYP2C9, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 3.114E-05 | 6.850E-05 | CYP2C9, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.933E-05 | 7.210E-05 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 9.290E-05 | 1.460E-04 | CYP2C9, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.372E-04 | 3.262E-04 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 6.884E-03 | 8.414E-03 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 8.675E-03 | 9.543E-03 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|